The U.S. Agency for International Development (USAID) shipped thousands of viral samples to a lab in Wuhan over the course of a 10-year program even though it had no formal agreement with the lab in place, according to previously unreported documents.
The documents show that USAID funded the exportation of 11,000 samples from Yunnan Province, where some of the closest relatives of the COVID-19 virus circulate, to Wuhan, the epicenter of the pandemic, with no apparent plan for ensuring the samples were not misdirected to bioweapons and remained accessible to the U.S. government.
A $210 million USAID public health program called PREDICT, steered by the University of California-Davis, collected viral samples in countries throughout the globe but lacked long-term storage when funding dried up, according to rudimentary plans in 2019.
USAID’s sample dispensation plan for China is sparse: “No need [sic] information from Yunnan. They were never an official lab partner for PREDICT. All samples they helped collected [sic] are sent to, tested, and stored in Wuhan.”
The “lab” refers to the Wuhan Institute of Virology (WIV). WIV was a close partner of USAID contractor EcoHealth Alliance and a slated partner for a PREDICT-like program supported by the State Department. The lab has poor biosafety practices and ties to the People’s Liberation Army (PLA).
Delusions of Adequacy 